| Literature DB >> 28127480 |
Jayaweera Arachchige Asela Sampath Jayaweera1, Mahen Kothalawala2, Balachandran Devakanthan2, Sinnappoo Arunan3, Dinithi Galgamuwa3, Manori Rathnayake3.
Abstract
All over the globe, the incidence of vertebral infection is rising. Nowadays, compared to tuberculous variety, pyogenic spondylodiscitis incidence is high. The increase in the susceptible population and improved diagnostics summatively contributed to this. In clinical grounds, differentiation of pyogenic and tuberculous spondylodiscitis is well defined. Enterobacter agglomerans is a hospital contaminant and associated with infections in immunocompromised individuals and intravenous lines. It causes a wide array of infections. Enterobacter agglomerans spondylodiscitis is unusual and there are, around the globe, only less than 31 suspected cases that have been previously reported. Enterobacter agglomerans histology mimics tuberculous rather than pyogenic spondylodiscitis. A 65-year-old farming lady, while being in hospital, developed sudden onset spastic paraparesis with hyperreflexia. Later blood culture revealed Enterobacter agglomerans with 41-hour incubation in 99.9% probability from Ramel identification system. Her initial ESR was 120 mm/first hour. Isolate was susceptible to ciprofloxacin and intravenous followed with oral therapy shows a drastic ESR fall and improved clinical response. Differentiation of tuberculous and pyogenic spondylodiscitis is very much important in management point of view. Therefore, blood culture has a role in diagnosis of spondylodiscitis. ESR can be used as important inflammatory marker in monitoring the response to treatment. Retrospectively, ESR would aid in reaching a definitive diagnosis.Entities:
Year: 2016 PMID: 28127480 PMCID: PMC5227132 DOI: 10.1155/2016/8491571
Source DB: PubMed Journal: Case Rep Infect Dis
Figure 1MRI thoracic spine T10-T11 discitis with minimal soft-tissue component and vertebral body.
Figure 2CT thoracic spine shows T10 vertebral body destruction.
Clinical response and change of ESR with time following parenteral and oral ciprofloxacin treatment.
| Week 0 | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | |
|---|---|---|---|---|---|---|---|
| ESR mm/1st hr | 120 | 100 | 80 | 70 | 26 | 12 | 13 |
| Lower limb power | 0/5 | 0/5 | 1/5 | 1/5 | 3/5 | 4/5 | 5/5 |
Figure 3CT thoracic spine shows T10-T11 vertebral body and disc regeneration.